Integration of Transcriptome and MicroRNA Profile Analysis of iMSCs Defines Their Rejuvenated State and Conveys Them into a Novel Resource for Cell Therapy in Osteoarthritis

Although MSCs grant pronounced potential for cell therapies, several factors, such as their heterogeneity restrict their use. To overcome these limitations, iMSCs (MSCs derived from induced pluripotent stem cells (iPSCs) have attracted attention. Here, we analyzed the transcriptome of MSCs, iPSCs an...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Cells
المؤلفون الرئيسيون: Vasileios Konteles, Ioanna Papathanasiou, Maria Tzetis, Evgenios Goussetis, Varvara Trachana, Evanthia Mourmoura, Charalampos Balis, Konstantinos Malizos, Aspasia Tsezou
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2023-06-01
الموضوعات:
الوصول للمادة أونلاين:https://www.mdpi.com/2073-4409/12/13/1756
الوصف
الملخص:Although MSCs grant pronounced potential for cell therapies, several factors, such as their heterogeneity restrict their use. To overcome these limitations, iMSCs (MSCs derived from induced pluripotent stem cells (iPSCs) have attracted attention. Here, we analyzed the transcriptome of MSCs, iPSCs and iMSCs derived from healthy individuals and osteoarthritis (OA) patients and explored miRNA-mRNA interactions during these transitions. We performed RNA-seq and gene expression comparisons and Protein-Protein-Interaction analysis followed by GO enrichment and KEGG pathway analyses. MicroRNAs’ (miRNA) expression profile using miRarrays and differentially expressed miRNA’s impact on regulating iMSCs gene expression was also explored. Our analyses revealed that iMSCs derivation from iPSCs favors the expression of genes conferring high proliferation, differentiation, and migration properties, all of which contribute to a rejuvenated state of iMSCs compared to primary MSCs. Additionally, our exploration of the involvement of miRNAs in this rejuvenated iMSCs transcriptome concluded in twenty-six miRNAs that, as our analysis showed, are implicated in pluripotency. Notably, the identified here interactions between hsa-let7b/i, hsa-miR-221/222-3p, hsa-miR-302c, hsa-miR-181a, hsa-miR-331 with target genes <i>HMGA2</i>, <i>IGF2BP3</i>, <i>STARD4</i>, and <i>APOL6</i> could prove to be the necessary tools that will convey iMSCs into the ideal mean for cell therapy in osteoarthritis.
تدمد:2073-4409